Literature DB >> 28866688

Alpha-Synuclein to the Rescue: Immune Cell Recruitment by Alpha-Synuclein during Gastrointestinal Infection.

Viviane Labrie1, Patrik Brundin.   

Abstract

Intraneuronal accumulation of misfolded alpha-synuclein in the central and peripheral nervous systems is strongly linked to Parkinson disease (PD) and other related synucleinopathies. In rare inherited forms of PD, point mutations or gene multiplications mediate the formation of alpha-synuclein protein aggregates. However, in most PD cases it is presumed that the combined effects of ageing and environmental factors drive the formation of alpha-synuclein aggregates. Despite advances regarding alpha-synuclein pathobiology, the normal functions of this protein and factors that regulate its expression are not well understood. We discuss a recent study reporting that viral infection induces alpha-synuclein expression in neurons of the gastrointestinal tract. Alpha-synuclein levels increased during norovirus infection in the duodenum of children. In an in vitro paradigm, monomeric and oligomeric alpha-synuclein acted as chemoattractants for neutrophils and monocytes, and promoted the maturation of dendritic cells. This suggests that alpha-synuclein facilitates immune responses to infection. We explore the possibility that intestinal infections, and associated inflammation, place individuals at increased risk of PD by increasing alpha-synuclein levels and promoting the formation of alpha-synuclein aggregates that propagate in a prion-like fashion via the vagal nerve to the brainstem.
© 2017 S. Karger AG, Basel.

Entities:  

Keywords:  Alpha-synuclein; Chemoattractant; Immune cells; Inflammation; Intestine; Parkinson disease; Virus

Mesh:

Substances:

Year:  2017        PMID: 28866688      PMCID: PMC5607025          DOI: 10.1159/000479653

Source DB:  PubMed          Journal:  J Innate Immun        ISSN: 1662-811X            Impact factor:   7.349


  39 in total

1.  alpha-Synuclein locus triplication causes Parkinson's disease.

Authors:  A B Singleton; M Farrer; J Johnson; A Singleton; S Hague; J Kachergus; M Hulihan; T Peuralinna; A Dutra; R Nussbaum; S Lincoln; A Crawley; M Hanson; D Maraganore; C Adler; M R Cookson; M Muenter; M Baptista; D Miller; J Blancato; J Hardy; K Gwinn-Hardy
Journal:  Science       Date:  2003-10-31       Impact factor: 47.728

Review 2.  When does Parkinson disease start?

Authors:  Rodolfo Savica; Walter A Rocca; J Eric Ahlskog
Journal:  Arch Neurol       Date:  2010-07

Review 3.  Role of α-synuclein in inducing innate and adaptive immunity in Parkinson disease.

Authors:  Heather E Allen Reish; David G Standaert
Journal:  J Parkinsons Dis       Date:  2015       Impact factor: 5.568

4.  Is alpha-synuclein in the colon a biomarker for premotor Parkinson's disease? Evidence from 3 cases.

Authors:  Kathleen M Shannon; Ali Keshavarzian; Hemraj B Dodiya; Shriram Jakate; Jeffrey H Kordower
Journal:  Mov Disord       Date:  2012-05-01       Impact factor: 10.338

5.  Gut Microbiota Regulate Motor Deficits and Neuroinflammation in a Model of Parkinson's Disease.

Authors:  Timothy R Sampson; Justine W Debelius; Taren Thron; Stefan Janssen; Gauri G Shastri; Zehra Esra Ilhan; Collin Challis; Catherine E Schretter; Sandra Rocha; Viviana Gradinaru; Marie-Francoise Chesselet; Ali Keshavarzian; Kathleen M Shannon; Rosa Krajmalnik-Brown; Pernilla Wittung-Stafshede; Rob Knight; Sarkis K Mazmanian
Journal:  Cell       Date:  2016-12-01       Impact factor: 41.582

6.  Medical records documentation of constipation preceding Parkinson disease: A case-control study.

Authors:  R Savica; J M Carlin; B R Grossardt; J H Bower; J E Ahlskog; D M Maraganore; A E Bharucha; W A Rocca
Journal:  Neurology       Date:  2009-11-24       Impact factor: 9.910

7.  Exposure to the Functional Bacterial Amyloid Protein Curli Enhances Alpha-Synuclein Aggregation in Aged Fischer 344 Rats and Caenorhabditis elegans.

Authors:  Shu G Chen; Vilius Stribinskis; Madhavi J Rane; Donald R Demuth; Evelyne Gozal; Andrew M Roberts; Rekha Jagadapillai; Ruolan Liu; Kyonghwan Choe; Bhooma Shivakumar; Francheska Son; Shunying Jin; Richard Kerber; Anthony Adame; Eliezer Masliah; Robert P Friedland
Journal:  Sci Rep       Date:  2016-10-06       Impact factor: 4.379

Review 8.  Parkinson's disease: a dual-hit hypothesis.

Authors:  C H Hawkes; K Del Tredici; H Braak
Journal:  Neuropathol Appl Neurobiol       Date:  2007-10-24       Impact factor: 8.090

Review 9.  The Synaptic Function of α-Synuclein.

Authors:  Jacqueline Burré
Journal:  J Parkinsons Dis       Date:  2015       Impact factor: 5.568

Review 10.  Gut Feelings About α-Synuclein in Gastrointestinal Biopsies: Biomarker in the Making?

Authors:  Claudio Ruffmann; Laura Parkkinen
Journal:  Mov Disord       Date:  2016-01-22       Impact factor: 10.338

View more
  11 in total

1.  Another Brick in the Wall.

Authors:  Heiko Herwald; Arne Egesten
Journal:  J Innate Immun       Date:  2019-02-26       Impact factor: 7.349

2.  Prevalence and outcomes of Covid-19 in Parkinson's disease: Acute settings and hospital.

Authors:  Conor Fearon; Alfonso Fasano
Journal:  Int Rev Neurobiol       Date:  2022-04-20       Impact factor: 4.280

Review 3.  Upregulating Human Cathelicidin Antimicrobial Peptide LL-37 Expression May Prevent Severe COVID-19 Inflammatory Responses and Reduce Microthrombosis.

Authors:  Karim M Aloul; Josefine Eilsø Nielsen; Erwin B Defensor; Jennifer S Lin; John A Fortkort; Mehrdad Shamloo; Jeffrey D Cirillo; Adrian F Gombart; Annelise E Barron
Journal:  Front Immunol       Date:  2022-05-12       Impact factor: 8.786

Review 4.  Possible Link between SARS-CoV-2 Infection and Parkinson's Disease: The Role of Toll-Like Receptor 4.

Authors:  Carmela Conte
Journal:  Int J Mol Sci       Date:  2021-07-01       Impact factor: 5.923

5.  Triptolide Inhibits Preformed Fibril-Induced Microglial Activation by Targeting the MicroRNA155-5p/SHIP1 Pathway.

Authors:  Yang Feng; Chuyun Zheng; Yajun Zhang; Changyang Xing; Wenbin Cai; Ruru Li; Jianzong Chen; Yunyou Duan
Journal:  Oxid Med Cell Longev       Date:  2019-04-28       Impact factor: 6.543

Review 6.  Therapies to Slow, Stop, or Reverse Parkinson's Disease.

Authors:  Tom Foltynie; J William Langston
Journal:  J Parkinsons Dis       Date:  2018       Impact factor: 5.568

7.  Inflammatory Bowel Diseases and Parkinson's Disease.

Authors:  Tomasz Brudek
Journal:  J Parkinsons Dis       Date:  2019       Impact factor: 5.568

Review 8.  Is the Enzyme ACMSD a Novel Therapeutic Target in Parkinson's Disease?

Authors:  Keerthi Thirtamara-Rajamani; Peipei Li; Martha L Escobar Galvis; Viviane Labrie; Patrik Brundin; Lena Brundin
Journal:  J Parkinsons Dis       Date:  2017       Impact factor: 5.568

Review 9.  The Intersection of Parkinson's Disease, Viral Infections, and COVID-19.

Authors:  Benjamin Rosen; Alberim Kurtishi; Gonzalo R Vazquez-Jimenez; Simon Geir Møller
Journal:  Mol Neurobiol       Date:  2021-05-25       Impact factor: 5.590

10.  The Possible Protective Role of α-Synuclein Against Severe Acute Respiratory Syndrome Coronavirus 2 Infections in Patients With Parkinson's Disease.

Authors:  Sofiane Ait Wahmane; Abderrahmane Achbani; Zakaria Ouhaz; Mohamed Elatiqi; Ahmed Belmouden; Mohamed Nejmeddine
Journal:  Mov Disord       Date:  2020-07-16       Impact factor: 9.698

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.